Clorhexidine Versus Povidone for the Prevention of Surgical Site Infection After Cesarean Section

Sponsor
Saint Thomas Hospital, Panama (Other)
Overall Status
Completed
CT.gov ID
NCT01741649
Collaborator
(none)
800
1
2
6
133.8

Study Details

Study Description

Brief Summary

Many solutions are used for cleaning the skin of a patient previous to a surgery. Although the efficacy of clorhexidine has been proved in other surgical procedures, there is only a retrospective study in cesarean section (they report no benefit of one solution over the other). The investigators would like to evaluate the difference in surgical site infection in patients after cesarean section comparing preparation of the skin with clorhexidine versus povidone.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Clorhexidine
  • Procedure: Povidone
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
800 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Clorhexidine Versus Povidone for the Prevention of Surgical Site Infection in Patients After Cesarean Section. Randomized, Controlled Trial.
Study Start Date :
Oct 1, 2012
Actual Primary Completion Date :
Mar 1, 2013
Actual Study Completion Date :
Apr 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Clorhexidine

Skin prior to the surgical incision will be cleaned for five minutes with Clorhexidine.

Procedure: Clorhexidine
Cleaning of the surgical site previous to the incision with a clorhexidine solution for five minutes.

Experimental: Povidone

Skin prior to surgical incision will be cleaned for five minutes with a povidine solution.

Procedure: Povidone
Cleaning of the surgical site previous to the incision with a povidone solution for five minutes.

Outcome Measures

Primary Outcome Measures

  1. Surgical Site infection (SSI) [3 days]

    The patients will be evaluated for evidence of surgical site infection before leaving the hospital, three (3) days after surgery. The presence of fever, suppurative secretion through the wound or cutaneous changes compatible witn infection will be considered a surgical site infection (SSI). This outcome will be evaluated with a qualitative variable (presence of SSI). The patients will be classified in accordance as "With SSI" or "Without SSI".

Secondary Outcome Measures

  1. Hospitalization [15 days]

    The patients will be evaluated for evidence of surgical site infection 15 days post surgery. The need to admit the patient to the hospital for management of a surgical site infection will be classified with "Hospitalization - Yes/No".

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Gestational age > 32 weeks

  • Emergency cesarean section

Exclusion Criteria:
  • Allergy to clorhexidine

  • Allergy to povidone

  • Evidence of infection in the surgical site

  • Loss to follow up at 15 days

  • Surgeries that due to the emergency of the case do not allow the five minutes of skin cleaning.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saint Thomas Maternity Hospital Panama Panama

Sponsors and Collaborators

  • Saint Thomas Hospital, Panama

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Osvaldo A. Reyes T., Coordinator of Research, Saint Thomas Hospital, Panama
ClinicalTrials.gov Identifier:
NCT01741649
Other Study ID Numbers:
  • MHST2012-04
First Posted:
Dec 5, 2012
Last Update Posted:
May 17, 2013
Last Verified:
May 1, 2013
Keywords provided by Osvaldo A. Reyes T., Coordinator of Research, Saint Thomas Hospital, Panama
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 17, 2013